Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Apple Valley › NPI 1013216951
Physician

Melinda D. Labuguen, MD INC.

Melinda D. Labuguen, MD INC. was paid $946K by Medicaid between Jan 2018 and Oct 2022, across 90 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 14% of everything it billed.

33Billing provider infoMELINDA D. LABUGUEN, MD INC.
APPLE VALLEY, CA 92307
33aNPI1013216951assigned 03/17/2011
28Total paid$946K
24GClaims464,393
24DCodes billed90
24AFirst – last monthJan 2018 – Oct 2022
Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in California

Rank by total paid#39 of 222
Median peer was paid$42K
This provider vs. median22×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201897,098$208K
201994,717$191K
202081,655$158K
202197,643$190K
202293,280$198K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
88305 Level IV - Surgical pathology, gross and microscopic examination 14% 4,054 3,831 $135K
80053 Comprehensive metabolic panel 11% 58,338 46,608 $100K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 9.8% 72,281 56,626 $92K
88304 7.7% 3,127 3,038 $73K
88307 6.2% 869 848 $59K
83880 5.3% 8,813 8,097 $50K
84484 4.5% 22,699 20,300 $42K
84702 4.3% 16,227 15,030 $40K
80048 Basic metabolic panel (calcium, ionized) 2.8% 18,601 12,436 $26K
83735 2.4% 19,748 12,967 $23K
83690 2.2% 18,471 16,976 $21K
88342 2.2% 639 626 $20K
78 more codes
84443 Thyroid stimulating hormone (TSH) 2.1% 7,198 $20K
81001 2.0% 36,084 $19K
85730 2.0% 17,751 $19K
87040 1.9% 9,650 $18K
83605 1.5% 7,646 $15K
85610 1.3% 18,573 $13K
87631 1.3% 1,064 $12K
82948 1.2% 10,151 $12K
85379 1.2% 6,786 $11K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 1.1% 1,967 $10K
80061 Lipid panel <1% 4,106 $9K
83036 Hemoglobin; glycosylated (A1C) <1% 5,283 $8K
85027 <1% 7,098 $7K
84703 <1% 5,829 $7K
84439 <1% 4,629 $7K
80202 <1% 2,907 $7K
86901 <1% 12,956 $6K
86900 <1% 12,747 $6K
86850 <1% 9,423 $5K
82728 <1% 2,131 $4K
87077 <1% 2,638 $4K
88108 <1% 210 $3K
82140 <1% 1,257 $3K
86880 <1% 2,890 $3K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 329 $2K
82607 <1% 760 $2K
82570 <1% 2,057 $2K
80076 <1% 1,582 $2K
82248 <1% 2,132 $2K
83615 <1% 1,912 $2K
87205 <1% 2,414 $2K
82247 <1% 1,826 $2K
82746 <1% 636 $2K
87210 <1% 2,102 $1K
87149 <1% 79 $1K
84100 <1% 1,670 $1K
82010 <1% 965 $1K
87147 <1% 1,613 $1K
87430 <1% 655 $1K
87075 <1% 590 $979.83
88311 <1% 204 $959.15
82565 <1% 821 $671.18
82731 <1% 64 $664.95
81003 <1% 1,718 $597.43
83540 <1% 552 $589.14
88341 <1% 12 $500.55
86592 <1% 669 $467.32
85060 <1% 40 $442.09
83550 <1% 324 $420.53
85384 <1% 265 $397.60
84156 <1% 604 $350.80
82272 <1% 304 $339.64
82550 <1% 332 $332.68
82962 <1% 156 $314.82
82150 <1% 255 $261.09
86870 <1% 61 $193.50
85046 <1% 203 $160.35
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 92 $143.64
89051 <1% 42 $143.59
84300 <1% 167 $134.92
85652 <1% 308 $131.96
85045 <1% 138 $98.13
87086 Culture, bacterial; quantitative colony count, urine <1% 77 $93.16
88300 <1% 14 $71.99
84478 <1% 72 $56.71
87081 <1% 59 $52.30
82270 <1% 105 $52.12
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 41 $48.64
84550 <1% 59 $45.83
87070 <1% 23 $31.32
86762 <1% 12 $29.80
87186 <1% 21 $29.75
82947 <1% 28 $29.49
84132 <1% 45 $29.21
87076 <1% 14 $24.32
85049 <1% 27 $18.75
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 0% 231 $0.00
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 0% 71 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLABUGUEN, MELINDA (PRESIDENT)